Public Law 114-63 | Public Law 114–63: To permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.

As enacted: this collection preserves GovInfo's listed Beta USLM public-law XML, including printed amendment instructions and legislative history. Later amendments are not consolidated here; availability in this XML inventory does not establish completeness of all laws enacted by Congress.

PUBLIC LAW 114–63—OCT. 7, 2015

129 STAT. 549

Public Law

114–63

114th Congress

An Act

To permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.

Oct. 7, 2015

[S. 139]

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

Ensuring Access to Clinical Trials Act of 2015.

42 USC 1305 note.

SECTION 1.

SHORT TITLE.

This Act may be cited as the “

Ensuring Access to Clinical Trials Act of 2015

”.

SEC. 2.

42 USC 1382a note.

ELIMINATION OF SUNSET PROVISION.

Effective as if included in the enactment of the Improving Access to Clinical Trials Act of 2009 (Public Law 111–255, 124 Stat. 2640), section 3 of that Act

is amended

striking

subsection (e).

Approved October 7, 2015.

LEGISLATIVE HISTORY—S. 139:

CONGRESSIONAL RECORD, Vol. 161 (2015):

July 16, considered and passed Senate.

Sept. 28, considered and passed House.

○

Public Law 114–63: To permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.

SHORT TITLE.

ELIMINATION OF SUNSET PROVISION.

LEGISLATIVE HISTORY—S. 139:

CONGRESSIONAL RECORD, Vol. 161 (2015):

Continue your research in ChatGPT or Claude